Astrana Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 09/30/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.2 | $2.0 | $1.4 | $1.1 | — |
| Operating income | $0.1 | $0.1 | $0.1 | $0.1 | — |
| Net income | $<0.1 | $<0.1 | $0.1 | $<0.1 | — |
| Balance Sheet | |||||
| Total debt | $1.1 | $0.4 | $0.3 | $0.2 | — |
| Cash Flow Statement | |||||
| Free cash flow | $0.1 | $<0.1 | $<0.1 | $0.1 | — |
| Dividends | $<0.1 | $<0.1 | $0.1 | $<0.1 | — |
| Share repurchases | $<0.1 | $<0.1 | $<0.1 | $<0.1 | — |
Shares outstanding 55.7M · Free float 52.8%
Annual filing data through FY ended December 31, 2025; float as of October 10, 2026.